William Pao

William Pao is a physician-scientist whose career has spanned academia, industry and biotech. He started his career as a thoracic oncologist, lab researcher and clinical investigator at Memorial Sloan-Kettering Cancer Center in New York and then Vanderbilt University in Nashville, where he also served as the Division Chief of Hematology/Oncology. Through senior executive leadership positions at Roche and Pfizer, he oversaw the discovery and development of portfolios of new molecular entities, many of which have been approved, to treat a variety of diseases. He currently is CEO and Co-Founder of a cancer biotechnology company. In addition to serving as an Independent Board Member for Alentis Therapeutics and Immunocore, he is on the Council of Visitors of the Vanderbilt School of Medicine Basic Sciences and he previously served an elected term on the Board of Directors for the American Association for Cancer Research. He is author of the book, Breakthrough: The Quest for Life-Changing Medicines.